Evidence map›Paper›PMID 40326866›Full record

ArticleeLife2025

RAG suppresses group 2 innate lymphoid cells.

Aaron M Ver Heul, Madison Mack, Lydia Zamidar, Masato Tamari, Ting-Lin Yang, Anna M Trier, Do-Hyun Kim, Hannah Janzen-Meza, Steven J Van Dyken, Chyi-Song Hsieh and 3 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Aaron M Ver HeulDivision of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, United States.ORCID https://orcid.org/0000-0003-3386-8351
Madison MackImmunology and Inflammation Research Therapeutic Area, Sanofi, Cambridge, United States.
Lydia ZamidarKimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.
Masato TamariKimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.
Ting-Lin YangDivision of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, United States.ORCID https://orcid.org/0000-0002-4808-7665
Anna M TrierDivision of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, United States.
Do-Hyun KimDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, United States.
Hannah Janzen-MezaDivision of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, United States.
Steven J Van DykenDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, United States.
Chyi-Song HsiehDivision of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, United States.
Jenny M KaroImmunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medical College, New York, United States.
Joseph C SunImmunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medical College, New York, United States.
Brian S KimKimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, United States.ORCID https://orcid.org/0000-0002-8100-7161

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Neuroimmune Regulation of Atopic DermatitisR01AR070116 · NIAMS · WASHINGTON UNIVERSITY · PI KIM, BRIAN · 2016 to 2021
$3.8M
Regulation of IgE and Atopic ItchR01AI167933 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CONROY, MICHELLE E, KIM, BRIAN · 2022 to 2025
$3.2M
Natural Killer Cell Regulation of Skin InflammationR01AR077007 · NIAMS · WASHINGTON UNIVERSITY · PI KIM, BRIAN · 2021 to 2025
$2.5M
The Role of IL-33 in Chronic ItchR21AI167047 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KIM, BRIAN · 2021 to 2022
$460k
Skin Neuroimmune Mechanisms of Urticarial ItchK08AR080219 · NIAMS · WASHINGTON UNIVERSITY · PI VER HEUL, AARON · 2022 to 2024
$438k
Epithelial Regulation of Chronic ItchF30AI154912 · NIAID · WASHINGTON UNIVERSITY · PI TRIER, ANNA MEREDITH · 2020 to 2021
$82k
Japanese Society of Allergology International ScholarshipNational Institute of Allergy and Infectious Diseases AI007163National Institute of Allergy and Infectious Diseases AI154912National Institute of Allergy and Infectious Diseases AI167047National Institute of Allergy and Infectious Diseases AI167933NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA091842NIAID NIH HHS F30 AI154912NIAID NIH HHS R01 AI167933NIAID NIH HHS R21 AI167047NIAID NIH HHS T32 AI007163NIAMS NIH HHS AR070116NIAMS NIH HHS AR077007NIAMS NIH HHS AR080219NIAMS NIH HHS K08 AR080219NIAMS NIH HHS R01 AR070116NIAMS NIH HHS R01 AR077007
6 · The paper itself

Abstract

Antigen specificity is the central trait distinguishing adaptive from innate immune function. Assembly of antigen-specific T cell and B cell receptors occurs through V(D)J recombination mediated by the Recombinase Activating Gene endonucleases RAG1 and RAG2 (collectively called RAG). In the absence of RAG, mature T and B cells do not develop and thus RAG is critically associated with adaptive immune function. In addition to adaptive T helper 2 (Th2) cells, group 2 innate lymphoid cells (ILC2s) contribute to type 2 immune responses by producing cytokines like Interleukin-5 (IL-5) and IL-13. Although it has been reported that RAG expression modulates the function of innate natural killer (NK) cells, whether other innate immune cells such as ILC2s are affected by RAG remains unclear. We find that in RAG-deficient mice, ILC2 populations expand and produce increased IL-5 and IL-13 at steady state and contribute to increased inflammation in atopic dermatitis (AD)-like disease. Furthermore, we show that RAG modulates ILC2 function in a cell-intrinsic manner independent of the absence or presence of adaptive T and B lymphocytes. Lastly, employing multiomic single cell analyses of RAG1 lineage-traced cells, we identify key transcriptional and epigenomic ILC2 functional programs that are suppressed by a history of RAG expression. Collectively, our data reveal a novel role for RAG in modulating innate type 2 immunity through suppression of ILC2s.

Indexed as

DNA-Binding ProteinsHomeodomain ProteinsImmunity, InnateLymphocytesAnimalsInterleukin-13Interleukin-5MiceMice, Inbred C57BLMice, KnockoutDNA-Binding ProteinsHomeodomain ProteinsInterleukin-13Interleukin-5RAG-1 proteinRag2 protein, mouseallergicatopicdermatitisimmunologyinflammationinnate lymphoid cellmouseRAG

Identifiers

PMID40326866
PMCPMC12055012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.